Which Initial Combination for Type 2Diabetes
(2024). Which Initial Combination for Type 2Diabetes. EKB Journal Management System, 4(2), -. doi: 10.21608/esdlj.2024.456245
. "Which Initial Combination for Type 2Diabetes". EKB Journal Management System, 4, 2, 2024, -. doi: 10.21608/esdlj.2024.456245
(2024). 'Which Initial Combination for Type 2Diabetes', EKB Journal Management System, 4(2), pp. -. doi: 10.21608/esdlj.2024.456245
Which Initial Combination for Type 2Diabetes. EKB Journal Management System, 2024; 4(2): -. doi: 10.21608/esdlj.2024.456245

Which Initial Combination for Type 2Diabetes

Egyptian Society of Diabetes and Lipidology Journal
Volume 4, Issue 2, October 2024    PDF (1.32 M)
Document Type: Abstracts
DOI: 10.21608/esdlj.2024.456245
Abstract
The initial combination is the starting pharmacological intervention together with lifestyle changes for the management of most components of the Cardiovascular-Kidney Metabolic Syndrome (American Heart Association; November 2023) e.g. hypertension, heart failure, dyslipidemia, and chronic kidney disease. For type 2 diabetes, the VERIFY trial (Vildagliptin/Metformin vs. Metformin; 2019)  showed better outcomes for the initial combination vs. stepwise approach. 


Statistics
Article View: 25
PDF Download: 7